(Q35606502)

9 August 2017

1 reference

title

Myths and realities of antiemetic treatment (English)

1 reference

9 August 2017

Martin M

1

1 reference

9 August 2017

language of work or name

1 reference

1 December 1992

1 reference

The British Journal of Cancer. Supplement

9 August 2017

published in

1 reference

9 August 2017

volume

19

1 reference

9 August 2017

page(s)

S46-50; discussion S50-3

1 reference

A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Lack of antiemetic effect of high-dose metoclopramide.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Laparotomic eventration or colonic prolapse after chemotherapy-induced emesis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Re

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

Cancer Treatment Needs Better Antiemetics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149635

12 July 2018

Therapy-linked leukemia

1 reference

12 December 2020

High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial

1 reference

12 December 2020

Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model

1 reference

12 December 2020

[Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin]

1 reference

12 December 2020

A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study

1 reference

12 December 2020

The course of nausea and vomiting after high-dose cyclophosphamide

1 reference

12 December 2020

GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis

1 reference

12 December 2020

Anti-emetic efficacy of dexamethasone in combination for out-patients receiving cytotoxic chemotherapy

1 reference

12 December 2020

Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses

1 reference

12 December 2020

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

The Natural Course of Emesis After Carboplatin Treatment

1 reference

12 December 2020

Identifiers

PMC publication ID

2149635

1 reference

9 August 2017

1 reference